Last reviewed · How we verify
NCT06964867
Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
NA trial testing Multimedia Health Education in Vitreous Floaters in 300 participants. Currently enrolling.
1 June 2025
Quick facts
| Lead sponsor | Changzhou No.2 People's Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 300 |
| Start date | 1 December 2023 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 June 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Multimedia Health Education
Conditions studied
- Vitreous Floaters — all drugs for Vitreous Floaters →
- Anxiety — all drugs for Anxiety →
Sponsor
Changzhou No.2 People's Hospital
Who can join
Eligibility, any sex, with Vitreous Floaters or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The patients with vitreous floaters were randomly divided into to groups after excluding the possibility of coexisting ocular pathologies potentially confounding visual symptoms or vitreoretinal anatomy. The control group performed conventional oral education. The experimental group conducted multimedia health education activities on the basis of conventional oral education. Their VRQoL (Visual Function Questionnaire-25, VFQ-25) and anxiety status (State-Trait Anxiety Inventory, STAI) were evaluated before education and at the final follow-up. The demographic and clinical characteristics (gender, age, eduaction, duration of vitreous floaters, comorbidities and so on) were collected.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06964867
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Multimedia Health Education
Trials testing the same drug.
- NCT07493642 — Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease · NA · recruiting
- NCT07030946 — Multimedia Education to Reduce Anxiety and Improve Care Awareness in Cataract Surgery Patients · NA · recruiting
Other Changzhou No.2 People's Hospital trials
Trials by the same sponsor.
- NCT06337474 — An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia · EARLY_PHASE1 · recruiting
- NCT06404281 — γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors · Phase 1 · recruiting
- NCT06403111 — FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC · Phase 2 · recruiting
- NCT06405113 — FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer · Phase 2 · recruiting
- NCT06379451 — An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06964867 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changzhou No.2 People's Hospital
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06964867.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing